Terns Pharmaceuticals (TERN) Eyes Expansion Beyond China Amid Strong Analyst Sentiment

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is included in our list of the 11 Best Performing Stocks in the Last 12 Months.

On January 16, 2026, Terns Pharmaceuticals, Inc. (NASDAQ:TERN) announced that it has made a strategic amendment to its Exclusive Option and License Agreement with Hansoh (Shanghai) Healthtech Co., Ltd. Through this move, the company converted its prior non-exclusive, royalty-free license to certain patents into an exclusive, sublicensable, royalty-bearing, perpetual worldwide license, though not including the Hansoh Territory. The license pertains to therapeutic products containing TERN-701 as the sole active ingredient. The development helps the company strengthen its commercialization rights outside China, Taiwan, Hong Kong, and Macau.

Under the amendment, Terns Pharmaceuticals, Inc. (NASDAQ:TERN) will be liable to pay Hansoh a one-time upfront license fee of $1.0 million and tiered royalties of 0.75%-1.25% on annual net sales of 701 Products. However, these liabilities will be subject to reductions where applicable.

Meanwhile, in the previous month, Citizens revisited Terns Pharmaceuticals, Inc. (NASDAQ:TERN), raising its price target from $35 to $57, while reiterating an ‘Outperform’ rating. The bullish tone reflected the interim Phase 1 CARDINAL ASH update that featured TERN-701’s best-in-class profile, high deep molecular response rate in 1L, and strong activity post-asciminib and ponatinib in 2L.

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) focuses on developing small-molecule and combination therapies for NASH, oncology, and chronic liver disease. Its clinical-stage programs span FXR, VAP-1, THR-β, and GLP-1 targets.

While we acknowledge the potential of TERN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: What Are the Best Stocks to Buy Right Now? and 10 Stocks Under $1 That Will Explode.

Disclosure: None.